TRACY FLORY: Open Payments
NPI 1932145125 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 73 payments from 18 companies in 2025. Trend: 2023 $1,211 · 2024 $1,242 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $265 |
| AstraZeneca Pharmaceuticals LP | 11 | $222 |
| ABBVIE INC. | 11 | $164 |
| Amgen Inc. | 9 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
Products named: ELIQUIS, AIRSUPRA, VRAYLAR, OTEZLA, JARDIANCE, NURTEC ODT, REXULTI, CAPLYTA.
Industry payments across GA — which companies pay providers there.
